This paper explores the variety of use of real-world data and evidence for the assessment of drugs in five European countries: France, Germany Italy, Sweden and the United Kingdom. Link to the article
PUYOU DE POUVOURVILLE, G., CUNNINGHAM, D., FRICKE, F.U., LINDGREN, P. and MANTOVANI, L. (2023). Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study. Value in Health, 26(4), pp. 11-19.